Market Overview:
The global autologous cell therapy market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and technological advancements in autologous cell therapies. The global autologous cell therapy market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into bone marrow cells, epidermal cells, and other types of cells. The bone marrow cells segment is expected to account for a major share of the global autologous cell therapy market in 2018 owing to its wide range of applications in neurology, orthopedics, cancer treatment etc. On the basis of application, the market is divided into neurology applications such as cerebral palsy & stroke rehabilitation; orthopedics applications such as joint replacement & cartilage repair; cancer treatments such as leukemia & lymphoma; wound healing applications such as diabetic foot ulcers & venous leg ulcers; and other applications including cardiovascular diseases & aesthetics.
Product Definition:
Autologous cell therapy is the use of cells from a patient's own body to treat disease. The cells can be used in various ways, including being injected into the patient, put into a device that attaches to the outside of the patient's body, or implanted into the patient's body. Autologous cell therapy is important because it can help reduce inflammation and promote healing.
Bone Marrow:
Bone marrow is the soft tissue inside bones. It is a source of hematopoietic progenitor cells (HPC), which can be used for autologous and allogeneic transplantation, including stem cell therapy.
Epidermis:
The epidermis is the outermost layer of the skin. It contains no blood vessels and serves only as a protective barrier to prevent water, air, and other elements from entering into the body. The epidermis also has an important function in keeping harmful UV radiation out of the body. Hence, epidermal cells have been used for decades as a source for grafting or transplantation procedures to replace lost tissues such as skin layers damaged by burn injuries or severe sun exposure conditions.
Application Insights:
The other application segment accounted for the largest revenue share in 2017 and is expected to witness significant growth during the forecast period. Other applications include cardiovascular, ENT, ophthalmology, plastic surgery and others. The growing acceptance of advanced therapies such as gene therapy and stem cell based therapies has fueled the demand for autologous cell therapy in various fields including cancer treatment, wound healing & aesthetic procedures.
Autologous cell therapy finds extensive use across various medical specialties such as neurology/neurological disorders, orthopedics/joint replacement surgeries, oncology/cancer treatments and others (such as respiratory diseases). In addition to this autophagy plays a vital role in tumorigenesis through promoting tumor progression & invasiveness while restraining anti-tumor immune responses leading to high usage of these cells-based therapies across cancer treatment procedures.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of industry players and high adoption rate for advanced therapies are some factors contributing to its growth. In addition, increasing government initiatives to increase awareness regarding autologous cell therapy are expected to further fuel the regional market over the forecast period. For instance, in August 2018, Regenerative Medicine Canada organized an event called “Regenerative Medicine: An Introduction†that covered various aspects of stem cells and their application in regenerative medicine.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income coupled with growing medical tourism especially for advanced therapies such as autologous cell therapy. Furthermore, supportive government regulations and policies encouraging clinical research & development activities are also likely boost regional demand during the forecast years (2018-2030).
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. According to a study by the World Health Organization (WHO), chronic diseases are responsible for 63% of all deaths worldwide. This number is expected to increase to 73% by 2030. This presents a huge opportunity for autologous cell therapy products and services as they can be used to effectively treat various chronic diseases.
- Growing awareness about autologous cell therapy: There has been a growing awareness about the benefits of autologous cell therapy in recent years, thanks to increased marketing and promotional activities by manufacturers and service providers in this market space. As more people become aware of the potential benefits offered by these therapies, demand for them is likely to grow significantly in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Autologous Cell Therapy Market Research Report
By Type
Bone Marrow, Epidermis
By Application
Neurology, Orthopedics, Cancer, Wound Healing, Other
By Companies
BioTime, Pharmicell, BrainStorm Cell Therapeutics, Opexa Therapeutics, Vericel Corporation, Regeneus
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
147
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Autologous Cell Therapy Market Report Segments:
The global Autologous Cell Therapy market is segmented on the basis of:
Types
Bone Marrow, Epidermis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Neurology, Orthopedics, Cancer, Wound Healing, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BioTime
- Pharmicell
- BrainStorm Cell Therapeutics
- Opexa Therapeutics
- Vericel Corporation
- Regeneus
Highlights of The Autologous Cell Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bone Marrow
- Epidermis
- By Application:
- Neurology
- Orthopedics
- Cancer
- Wound Healing
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Autologous Cell Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Autologous cell therapy is a treatment that uses your own cells to treat a disease. These cells are taken from your own body and used to help heal or repair the damage caused by the disease.
Some of the key players operating in the autologous cell therapy market are BioTime, Pharmicell, BrainStorm Cell Therapeutics, Opexa Therapeutics, Vericel Corporation, Regeneus.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Autologous Cell Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Autologous Cell Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Autologous Cell Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Autologous Cell Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Autologous Cell Therapy Market Size & Forecast, 2018-2028
4.5.1 Autologous Cell Therapy Market Size and Y-o-Y Growth
4.5.2 Autologous Cell Therapy Market Absolute $ Opportunity
Chapter 5 Global Autologous Cell Therapy Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Autologous Cell Therapy Market Size Forecast by Type
5.2.1 Bone Marrow
5.2.2 Epidermis
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Autologous Cell Therapy Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Autologous Cell Therapy Market Size Forecast by Applications
6.2.1 Neurology
6.2.2 Orthopedics
6.2.3 Cancer
6.2.4 Wound Healing
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Autologous Cell Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Autologous Cell Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Autologous Cell Therapy Analysis and Forecast
9.1 Introduction
9.2 North America Autologous Cell Therapy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Autologous Cell Therapy Market Size Forecast by Type
9.6.1 Bone Marrow
9.6.2 Epidermis
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Autologous Cell Therapy Market Size Forecast by Applications
9.10.1 Neurology
9.10.2 Orthopedics
9.10.3 Cancer
9.10.4 Wound Healing
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Autologous Cell Therapy Analysis and Forecast
10.1 Introduction
10.2 Europe Autologous Cell Therapy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Autologous Cell Therapy Market Size Forecast by Type
10.6.1 Bone Marrow
10.6.2 Epidermis
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Autologous Cell Therapy Market Size Forecast by Applications
10.10.1 Neurology
10.10.2 Orthopedics
10.10.3 Cancer
10.10.4 Wound Healing
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Autologous Cell Therapy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Autologous Cell Therapy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Autologous Cell Therapy Market Size Forecast by Type
11.6.1 Bone Marrow
11.6.2 Epidermis
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Autologous Cell Therapy Market Size Forecast by Applications
11.10.1 Neurology
11.10.2 Orthopedics
11.10.3 Cancer
11.10.4 Wound Healing
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Autologous Cell Therapy Analysis and Forecast
12.1 Introduction
12.2 Latin America Autologous Cell Therapy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Autologous Cell Therapy Market Size Forecast by Type
12.6.1 Bone Marrow
12.6.2 Epidermis
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Autologous Cell Therapy Market Size Forecast by Applications
12.10.1 Neurology
12.10.2 Orthopedics
12.10.3 Cancer
12.10.4 Wound Healing
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Autologous Cell Therapy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Autologous Cell Therapy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Autologous Cell Therapy Market Size Forecast by Type
13.6.1 Bone Marrow
13.6.2 Epidermis
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Autologous Cell Therapy Market Size Forecast by Applications
13.10.1 Neurology
13.10.2 Orthopedics
13.10.3 Cancer
13.10.4 Wound Healing
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Autologous Cell Therapy Market: Competitive Dashboard
14.2 Global Autologous Cell Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BioTime
14.3.2 Pharmicell
14.3.3 BrainStorm Cell Therapeutics
14.3.4 Opexa Therapeutics
14.3.5 Vericel Corporation
14.3.6 Regeneus
